Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Defined term · Evidence assessment

Transitivity

The assumption, required for indirect comparison, that participants in the contributing trials could in principle have been randomised to any of the compared interventions. Assessed explicitly and…

Document identifier
CEI-GT-023
Series
Defined term
Version
1.0
Published
30 Jul 2026
Last reviewed
30 Jul 2026
Certainty
Not rated

§1Transitivity

§1.2Category

Evidence assessment — Terms describing how the Institute judges and reports the strength of evidence.

§1.3Related terms

  • Network meta-analysis — A synthesis combining direct and indirect comparisons across a connected set of interventions. The Institute publishes network estimates with its transitivity assessment…
  • Indirect comparison — An estimate of the difference between two interventions that have not been compared directly, derived through their comparisons with a common comparator. Weaker than a…
Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.